Should we rely on trials with disease- rather than patient-oriented endpoints?
Crossref DOI link: https://doi.org/10.1007/s00134-017-4859-0
Published Online: 2017-06-12
Published Print: 2018-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
de Grooth, Harm-Jan http://orcid.org/0000-0002-7499-076X
Parienti, Jean-Jacques
Oudemans-van Straaten, Heleen M.
License valid from 2017-06-12